Poster Combinatorial activity of amivantamab and pembrolizumab in head and neck squamous cell carcinoma and lung squamous cell carcinoma expressing wild-type EGFR and MET
페이지 정보
작성자 DAAN
조회 731회 작성일 23-04-18 10:21
조회 731회 작성일 23-04-18 10:21
본문
| Journal | AACR |
|---|---|
| Name | 임선민, 신춘봉, 강성산, 김동권 |
| Year | 2023 |
첨부파일
-
AACR_2023_JNJ_POSTER_FINAL.pdf (2.6M)
0회 다운로드 | DATE : 2023-04-18 10:22:28
- 이전글A novel bacterial strain, CJRB-101, induces anti-cancer effects by repolarization of M2 to CXCL9 and CXCL10 dual expressing M1 macrophages in humanized non-small cell lung cancer mice models 23.04.18
- 다음글Combination therapy with anti-PD-1 and YH29407, a novel IDO1 inhibitor, enhances T cell-mediated antitumor immunity in MC38 tumor-bearing mice 24.02.16